Vimarsana
Biggest News Aggregation in the World

Page 4 - Oddity Tech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oddity Tech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oddity Tech Today - Breaking & Trending Today

Oddity Tech (NASDAQ:ODD) Earns Outperform Rating from Analysts at Evercore ISI - Vimarsana News

Oddity Tech (NASDAQ:ODD) Earns Outperform Rating from Analysts at Evercore ISI

Evercore ISI started coverage on shares of Oddity Tech (NASDAQ:ODD – Free Report) in a report released on Thursday, Marketbeat.com reports. The firm issued an outperform rating and a $57.00 target price on the stock. Other analysts also recently issued reports about the stock. JMP Securities restated a market outperform rating and set a $66.00 […]

Oddity Tech (ODD) and Its Peers Financial Comparison - Vimarsana News

Oddity Tech (ODD) and Its Peers Financial Comparison

Oddity Tech (NASDAQ:ODD – Get Free Report) is one of 26 public companies in the “Toilet preparations” industry, but how does it contrast to its competitors? We will compare Oddity Tech to related companies based on the strength of its institutional ownership, dividends, risk, analyst recommendations, earnings, profitability and valuation. Valuation & Earnings This table […]

Source: wkrb13.com
3 Artificial Intelligence (AI) Stocks That Could Go Parabolic - Vimarsana News

3 Artificial Intelligence (AI) Stocks That Could Go Parabolic

These three stocks are just getting started and offer early-stage growth opportunities.

Source: yahoo.com
Oddity Tech (NASDAQ:ODD) Shares Gap Up to $37.80 - Vimarsana News

Oddity Tech (NASDAQ:ODD) Shares Gap Up to $37.80

Oddity Tech Ltd. (NASDAQ:ODD – Get Free Report)’s share price gapped up before the market opened on Thursday . The stock had previously closed at $37.80, but opened at $39.43. Oddity Tech shares last traded at $39.09, with a volume of 97,379 shares. Analyst Upgrades and Downgrades ODD has been the subject of a number […]

Equities Research Analysts' New Coverage for April 4th (ABIO, ACOR, AEMD, AGRX, AHPI, AIRI, ALUR, ATHX, AXDX, AZTA) - Vimarsana News

Equities Research Analysts' New Coverage for April 4th (ABIO, ACOR, AEMD, AGRX, AHPI, AIRI, ALUR, ATHX, AXDX, AZTA)

Equities Research Analysts’ new coverage for Thursday, April 4th: StockNews.com started coverage on shares of ARCA biopharma (NASDAQ:ABIO). The firm issued a sell rating on the stock. StockNews.com began coverage on shares of Acorda Therapeutics (NASDAQ:ACOR). The firm issued a buy rating on the stock. StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD). They […]